Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$726M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$599M |
| 3 |
Apple
AAPL
|
+$578M |
| 4 |
Meta Platforms (Facebook)
META
|
+$328M |
| 5 |
American Airlines Group
AAL
|
+$317M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.17B |
| 2 |
Gilead Sciences
GILD
|
+$392M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$285M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$225M |
| 5 |
Intel
INTC
|
+$208M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 85.51% |
| 2 | Technology | 3.09% |
| 3 | Consumer Discretionary | 2.15% |
| 4 | Financials | 1.67% |
| 5 | Healthcare | 1.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IMOS
4026
CALL
ChipMOS TECHNOLOGIES
IMOS
$1.93B
| $2.7M | ﹤0.01% |
112,262
-151,740
| -57% | -$3.9M |
|
4027
Piper Sandler
PIPR
$5.34B
| $2.7M | ﹤0.01% |
247,624
+104,700
| +73% | +$1.31M |
|
4028
Invesco S&P 500 Top 50 ETF
XLG
$11B
| $2.7M | ﹤0.01% |
190,820
-288,650
| -60% | -$4.16M |
|
4029
Carter's
CRI
$1.23B
| $2.7M | ﹤0.01% |
25,383
+5,429
| +27% | +$544K |
|
4030
Forward Air
FWRD
$574M
| $2.7M | ﹤0.01% |
51,601
+7,501
| +17% | +$395K |
|
|
CSOD
4031
CALL
DELISTED
Cornerstone OnDemand, Inc.
CSOD
| $2.7M | ﹤0.01% |
77,500
+46,800
| +152% | +$1.46M |
|
|
DRR
4032
DELISTED
Market Vectors Double Short Euro ETN
DRR
| $2.7M | ﹤0.01% |
46,580
-7,413
| -14% | -$436K |
|
|
BERY
4033
DELISTED
Berry Global Group, Inc.
BERY
| $2.7M | ﹤0.01% |
90,634
+27,645
| +44% | +$869K |
|
|
SNBR
4034
DELISTED
Sleep Number
SNBR
| $2.69M | ﹤0.01% |
89,607
-237,135
| -73% | -$7.5M |
|
4035
Synopsys
SNPS
$84.8B
| $2.69M | ﹤0.01% |
53,200
+14,212
| +36% | +$692K |
|
4036
Northern Trust Morningstar Global Upstream Natural Resources ETF
GUNR
$7.28B
| $2.69M | ﹤0.01% |
90,491
+18,266
| +25% | +$572K |
|
|
DBKO
4037
DELISTED
Xtrackers MSCI South Korea Hedged Equity ETF
DBKO
| $2.69M | ﹤0.01% |
115,045
+84,729
| +279% | +$2.05M |
|
4038
Genpact
G
$6.39B
| $2.69M | ﹤0.01% |
126,197
-14,399
| -10% | -$323K |
|
|
ADVM
4039
PUT
DELISTED
Adverum Biotechnologies
ADVM
| $2.69M | ﹤0.01% |
16,560
+13,500
| +441% | +$4.55M |
|
|
EGN
4040
DELISTED
Energen
EGN
| $2.69M | ﹤0.01% |
39,356
+16,380
| +71% | +$1.14M |
|
4041
CALL
Charles River Laboratories
CRL
$13.9B
| $2.69M | ﹤0.01% |
+38,200
| New | +$2.83M |
|
4042
PUT
Visteon
VC
$2.72B
| $2.69M | ﹤0.01% |
25,600
-95,900
| -79% | -$10.1M |
|
|
RUSL
4043
DELISTED
Direxion Daily Russia Bull 2X Shares
RUSL
| $2.69M | ﹤0.01% |
+55,305
| New | +$3.29M |
|
|
AVDL
4044
DELISTED
Avadel Pharmaceuticals
AVDL
| $2.69M | ﹤0.01% |
+126,774
| New | +$2.27M |
|
4045
Watsco Inc
WSO
$12.8B
| $2.69M | ﹤0.01% |
21,703
+13,589
| +167% | +$1.69M |
|
4046
CALL
Live Nation Entertainment
LYV
$42.3B
| $2.68M | ﹤0.01% |
97,600
-28,100
| -22% | -$767K |
|
4047
CALL
Factset
FDS
$11B
| $2.68M | ﹤0.01% |
16,500
+800
| +5% | +$130K |
|
|
PPO
4048
DELISTED
POLYPORE INTERNATIONAL, INC
PPO
| $2.68M | ﹤0.01% |
44,683
+19,674
| +79% | +$1.17M |
|
4049
CALL
Dentsply Sirona
XRAY
$2.22B
| $2.67M | ﹤0.01% |
51,900
-9,400
| -15% | -$487K |
|
4050
CALL
IPG Photonics
IPGP
$3.26B
| $2.67M | ﹤0.01% |
31,400
+5,700
| +22% | +$536K |
|
Similar funds
Jeff Yass's Q2 2015 Portfolio in Review
As of Q2 2015, Jeff Yass held 10,941 positions worth $235B, up 6.8% from $220B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Jeff Yass's Q2 2015 filing shows 1,599 new, 4,693 increased, 3,596 reduced and 888 closed positions. Its largest new stake was Vanguard Global ex-US Real Estate ETF: 1,789,597 shares worth $99.3M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.17B.
By sector, the portfolio is most concentrated in Miscellaneous at 86% of assets, down from 87% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q2 2015 buy was Vanguard Global ex-US Real Estate ETF: 1,789,597 shares worth $99.3M.
- Jeff Yass added most to Alphabet (Google) Class C in Q2 2015, an estimated $726M increase.
- Jeff Yass's biggest Q2 2015 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.17B.
- Jeff Yass fully exited ACTAVIS PLC Pfd Conv Ser A (Irl) in Q2 2015, selling an estimated $41.7M.
- Jeff Yass's ten largest holdings make up 24% of its $235B portfolio in Q2 2015.
- Jeff Yass opened 1,599 new positions and closed 888 in Q2 2015.
- Jeff Yass's portfolio value rose 6.8% quarter-over-quarter to $235B.
Based on Susquehanna International Group's 13F filing for Q2 2015, filed 14 Aug 2015.